Powered by: Motilal Oswal
2026-11-14 10:35:54 am | Source: Choice Institutional Equities Ltd
Buy Bajaj Consumer Care Ltd For Target Rs.690 by Choice Institutional Equities
Buy Bajaj Consumer Care Ltd For Target Rs.690 by Choice Institutional Equities

ADHO Turnaround Revives Volume-led Growth Momentum ADHO, after a prolonged phase of volume decline, market share erosion and margin pressure, witnessed a strong turnaround in FY26. The new management implemented a multi-pronged revival strategy focussed on volume-led growth, strategic pricing, portfolio mix optimisation and higher brand investments. BCCL’s revived sachets and INR 10/20 packs, improved distribution through “Project Aarohan,” and significantly increased advertising and digital spend, helped the core ADHO portfolio, which grew ~25% in FY26. Simultaneously, calibrated pricing, ml-age (grammage)- optimisation and tighter channel spending supported gradual margin recovery while sustaining a healthy volume growth.

Scaling up Non-ADHO ‘Growth Portfolio:’ Target of INR 5 Bn BCCL is scaling up its non-ADHO “Growth Portfolio,” comprising Coconut Oil, Banjara’s (personal care), and other emerging brands, with a target to increase revenue, from INR 2.25 Bn in FY26 to INR 5 Bn in the next three years. BCCL has shifted Coconut Oil towards a profitability-focused, brand-led strategy through calibrated pricing, mix improvement, and value-added offering, such as Bajaj Gold Enriched Coconut Hair Oil. Meanwhile, the VPCL (Banjara’s) acquisition strengthens BCCL’s South India presence and herbal portfolio, while Project Aarohan and rising Modern Trade/Ecommerce saliency continue to improve distribution, premiumisation and innovation capabilities across the portfolio.

Project Aarohan: Building a Stronger Distribution Engine for Long-term Growth Project Aarohan is BCCL’s large-scale Route-to-Market (RTM) transformation initiative aimed at strengthening distribution reach, outlet productivity and General Trade execution across both, ADHO and non-ADHO, portfolios. Since its rollout in FY25, the program has expanded across eight core states under Phase 1 and 2, increased direct reach by over 10% to nearly 6 lakh outlets and added 25,000– 38,000 new outlets through better rural penetration, distributor optimisation and technology-led execution using geotagging and geofencing. Aarohan states delivered 25%–40% higher outlet coverage and ~4% better growth versus nonimplementation states, significantly aiding GT recovery in FY26. Following the success of Phase 1 and 2, Project Aarohan has now entered Phase 3, expanding the initiative into Bihar, Gujarat, Jharkhand, Odisha, and Punjab to drive the next leg of distribution-led growth.

Valuation and View: Bajaj Consumer Care offers an attractive medium-term growth story, driven by ADHO recovery, scaling up of the non-ADHO Growth Portfolio, premiumisation and Project Aarohan-led distribution expansion. Sustained DoubleDigit growth, improving product mix and operating leverage are expected to drive Revenue/EBITDA/PAT CAGR of 15%/19%/19%, respectively, over FY26–29E. We initiate coverage with a ‘BUY’ rating and a one-year DCF-based target price of INR 690, implying 31% upside from the current level implying P/E of ~32x FY28E EPS and implied PEG of 1.8 (one of the lowest in the sector).

Upside Trigger: Faster scaling of the non-ADHO portfolio, successful execution of Project Aarohan Phase 3, sustained ADHO market share gains, and stronger traction in Modern Trade, E-commerce, and Quick Commerce.

Key Risks: Raw material inflation, Aggressive competitive pricing, Weaker rural demand, and slower than expected execution of Project Aarohan and Banjara’s integration.

 

For Detailed Report With Disclaimer Visit. https://choicebroking.in/disclaimer

SEBI Registration no.: INZ 000160131

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here